Santesoin Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Kanpur, Uttar Pradesh, India, established in 2013.
2013 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Santesoin Pharma Llp

Santesoin Pharma Llp, a active limited liability partnership, was established on 12 April 2013 in Kanpur, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAB-4596. Registered under ROC Roc Kanpur. It has total obligation of contribution of ₹0.20 M.

Its leadership includes Dharmendra Kumar (Designated Partner), Seema Agarwal (Designated Partner), Anup Agarwal (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Block No. 17, Shop No. - 10, Canal Road,, Kanpur, Uttar Pradesh, 208023.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAB-4596

  • Incorporation Date

    12 April 2013

  • Total Obligation of Contribution

    ₹0.20 M

  • ROC Code

    Roc Kanpur

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.20 M
  • Company Age 12 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Santesoin Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Santesoin Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Santesoin Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Dharmendra Kumar Designated Partner 12 Apr 2013 Current
Seema Agarwal Designated Partner 12 Apr 2013 Current
Anup Agarwal Designated Partner 12 Apr 2013 Current
Rashmi Agarwal Designated Partner 12 Apr 2013 Current
Manoj Kumar Agarwal Designated Partner 12 Apr 2013 Current
Vishal Bhusan Gupta Designated Partner 12 Apr 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Santesoin Pharma Llp.

Enhance accessibility to Santesoin Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Santesoin Pharma Llp revenue growth over time
Santesoin Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Santesoin Pharma Llp?

Unlock access to Santesoin Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Santesoin Pharma Llp?

Unlock and access historical data on people associated with Santesoin Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Santesoin Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santesoin Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Santesoin Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Santesoin Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Santesoin Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    Dharmendra Kumar was appointed as a Designated Partner was appointed as a Designated Partner on 12 Apr 2013 & has been associated with this company since 12 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Seema Agarwal was appointed as a Designated Partner was appointed as a Designated Partner on 12 Apr 2013 & has been associated with this company since 12 years 10 months . was completed.

  • Director Appointment

    Progress on Anup Agarwal was appointed as a Designated Partner was appointed as a Designated Partner on 12 Apr 2013 & has been associated with this company since 12 years 10 months . was documented.

  • Director Appointment

    Progress on Rashmi Agarwal was appointed as a Designated Partner was appointed as a Designated Partner on 12 Apr 2013 & has been associated with this company since 12 years 10 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Santesoin Pharma Llp?

The LLPIN of Santesoin Pharma Llp is AAB-4596.

Where is Santesoin Pharma Llp headquartered?

Santesoin Pharma Llp is headquartered at Block No. 17, Shop No. - 10, Canal Road,, Kanpur, Uttar Pradesh, 208023.

When was Santesoin Pharma Llp incorporated?

Santesoin Pharma Llp was incorporated on 12 April 2013.

Who are the current directors of Santesoin Pharma Llp?

The current directors of Santesoin Pharma Llp are

What is the primary industry of Santesoin Pharma Llp?

The primary industry of Santesoin Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available